180 Life Sciences Corp. Files 8-K: Agreements & Equity Sales
Ticker: FRMM · Form: 8-K · Filed: Feb 25, 2025 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | 180 Life Sciences CORP. (FRMM) |
| Form Type | 8-K |
| Filed Date | Feb 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, financials
TL;DR
180 Life Sciences filed an 8-K on Feb 21, 2025, covering new deals and stock sales.
AI Summary
On February 21, 2025, 180 Life Sciences Corp. filed an 8-K report detailing a material definitive agreement, unregistered sales of equity securities, and financial statements. The company, formerly known as KBL Merger Corp. IV, is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides crucial updates on the company's financial activities and contractual obligations, which can impact investor decisions and future performance.
Risk Assessment
Risk Level: medium — The filing mentions unregistered sales of equity securities, which can sometimes indicate dilution or financial distress.
Key Players & Entities
- 180 Life Sciences Corp. (company) — Registrant
- KBL Merger Corp. IV (company) — Former Company Name
- February 21, 2025 (date) — Date of earliest event reported
FAQ
What specific material definitive agreement was entered into by 180 Life Sciences Corp. on or before February 21, 2025?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What type of equity securities were sold unregistered by 180 Life Sciences Corp.?
The filing mentions 'Unregistered Sales of Equity Securities' but does not specify the type of securities in the provided text.
When did 180 Life Sciences Corp. change its name from KBL Merger Corp. IV?
The date of the name change from KBL Merger Corp. IV to 180 Life Sciences Corp. was November 15, 2016.
What is the Standard Industrial Classification (SIC) code for 180 Life Sciences Corp.?
The SIC code for 180 Life Sciences Corp. is 2834, which corresponds to Pharmaceutical Preparations.
What is the fiscal year end for 180 Life Sciences Corp.?
The fiscal year end for 180 Life Sciences Corp. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 25, 2025 regarding 180 Life Sciences Corp. (FRMM).